Table D.18Treatment pathway probabilities

VariableValueSourceNotes
Control with diet0.86Persson et al. (1985)172
Control with glibenclamide0.96Langer et al. (2000)74GDG member suggested that data from Southampton (their local practice) indicate a higher failure rate (23%).
Control with metformin0.96Assumed the same as for glibenclamide.
Hypoglycaemia on insulin therapy0.20Langer et al. (2000)74
Hypoglycaemia on insulin analogue0.20Assumed the same as for insulin.
Hypoglycaemia on glibenclamide0.02Langer et al. (2000)74
Hypoglycaemia on metformin0.02Assumed the same as for glibenclamide.
Severe hypoglycaemia requiring hospitalisation0.05GDG estimate

From: Appendix D, Cost-effectiveness of screening, diagnosis and treatment for gestational diabetes

Cover of Diabetes in Pregnancy
Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period.
NICE Clinical Guidelines, No. 63.
National Collaborating Centre for Women's and Children's Health (UK).
London: RCOG Press; 2008 Mar.
Copyright © 2008, National Collaborating Centre for Women’s and Children’s Health.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.